SightfileU.S. market data from official filings
Companies › BGM
BGM Group Ltd (BGM)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001779578 · EDGAR filings · Updated 2026-07-28
BGM Group Ltd (BGM) has reported institutional ownership of 0.1%, with 14 institutional managers holding positions valued at $63.4K per the latest 13F reporting period.
Institutional ownership
0.1%
Institutional managers
14
Reported 13F value
$63.4K
Filings this week (1)
- 2026-07-28 — Foreign issuer report (6-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-21 — Annual report (20-F) filed
- 2026-07-13 — Foreign issuer report (6-K) filed
- 2026-06-17 — Foreign issuer report (6-K) filed
- 2026-06-09 — Foreign issuer report (6-K) filed
- 2026-05-18 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BGM Group Ltd has 14 institutional holders and institutional ownership of 0.1%.
Related companies
IMMURON LTD (IMRN) · GRI Bio Inc (GRI) · Adial Pharmaceuticals Inc (ADIL) · SILEXION THERAPEUTICS CORP (SLXN) · LYRA THERAPEUTICS INC (LYRA) · PROPANC BIOPHARMA INC (PPCB)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.